Search alternatives:
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
441
-
442
-
443
-
444
-
445
-
446
-
447
GluN2A(D731N) decreases channel open probability.
Published 2017“…(<b>D,E</b>) The channel open probability was evaluated by measuring the degree of MTSEA (200 μM) potentiation using TEVC recordings from <i>Xenopus</i> oocytes expressing the WT GluN2A (<i>left panel</i>) or the mutant GluN2A(D731N) (<i>right panel</i>) coexpressed with GluN1(A652C) at a holding potential of -40 mV in presence of EC<sub>50</sub> concentrations of glutamate with saturating concentration (100 μM) of glycine (open bar) and 0.2 mM MTSEA (closed bar). …”
-
448
-
449
-
450
-
451
-
452
-
453
-
454
Decreased synaptic density in the CA1 hippocampal area.
Published 2013“…<p>PSD-95 (green, A and D) and SYN (red, B and E) antibodies were used to stain synapses (merged, C and F) in stratum radiatum (SR) of the hippocampal area CA1. …”
-
455
SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice.
Published 2012“…<p>(A), Lumen diameters (upper panel) of LC in SU9518 treated eNOS (−/−) mice were reduced in response to a remodeling stimulus but not in LC of vehicle treated eNOS (−/−) mice. …”
-
456
-
457
-
458
-
459
-
460
Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice.
Published 2022“…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”